Introduction
Brand name: QUITCAL‑M
Division: Essendon Products (under Astemax Biotech Pvt. Ltd.)
Composition per tablet:
Cyanocobalamin 1500 mcg (vitamin B12)
Calcium carbonate 200 mg
Vitamin D3 (cholecalciferol) 10 mcg (400 IU)
Folic acid 300 mcg
Pyridoxine hydrochloride 2 mg
Overview
QUITCAL‑M is a vitamin B12‑plus‑bone‑health supplement targeted at correcting vitamin B12 deficiency, supporting nerve‑health, and providing basic calcium and vitamin D support. Cyanocobalamin helps in red‑cell formation and neurological function, while calcium carbonate and vitamin D3 contribute to bone‑mineralization and musculoskeletal support. Folic acid and pyridoxine (vitamin B6) complement homocysteine metabolism and overall B‑complex status.
Typical use and precautions
Usual dose is typically 1 tablet once daily, preferably with food, as per local prescribing or OTC‑label guidance (exact regimen may vary by market).
Use cautiously in patients with renal stones, hypercalcaemia, severe renal impairment, or active vitamin D toxicity; monitor serum calcium and renal function in long‑term use.
Astemax markets QUITCAL‑M under the Essendon Products division as a FSSAI‑approved, WHO‑GMP‑compliant formulation suitable for physicians recommending vitamin B12‑based supportive therapy in neurological, haematological, and nutritional‑deficiency‑related conditions.
